Search Within

Myeloma

Formats
  1. Meeting Abstract (556)
  2. Journal Article (364)
  3. Review (37)
  4. Research Letter (21)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (7)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (1011)
  2. Department of Medicine (1011)
  3. Hematologic Malignancies, Division of (1011)
  4. Hematologic Malignancies Research (666)
  5. Survivorship Research (372)
  6. Bone Marrow Transplant (303)

More Groups

People
  1. Alexander Lesokhin (378)
  2. Hani Hassoun (338)
  3. Carl Landgren (336)
  4. Sham Mailankody (296)
  5. Malin Hultcrantz (271)
  6. Heather Landau (248)

More People

Years
  1. 2025 (23)
  2. 2024 (82)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (317)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (86)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (24)

More Publications

Publishers
  1. American Society of Hematology (339)
  2. Elsevier Inc. (160)
  3. American Society of Clinical Oncology (88)
  4. Nature Publishing Group (86)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (1011)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ibrutinib, single agent or in combination with dexamethasone, in patients with relapsed or relapsed/refractory multiple myeloma (MM): Preliminary phase 2 results
    Meeting Abstract

    Vij, R.; Huff, C. A.; Bensinger, W. I.; Siegel, D. S.; Jagannath, S.; Berdeja, J.; Lendvai, N.; Lebovic, D.; Anderson, L. D.; Costello, C. L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Plasma protease-mediated metabolism of carfilzomib and its implications on clinical effects and side effects
    Meeting Abstract

    Tristan, S. M.; Peer, C. J.; Korde, N.; Nehal, L.; Sham, M.; Landgren, O.; Figg, W. D.
    Blood (2014)

    Fulltext@MSK | Save
  • Obesity and risk of monoclonal gammopathy of undetermined significance: A population-based study
    Meeting Abstract

    Thordardottir, M.; Lund, S. H.; Lindqvist, E. K.; Costello, R.; Burton, D.; Korde, N.; Mailankody, S.; Eiriksdottir, G.; Launer, L. J.; Gudnason, V.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A systemic xenograft model of Waldenstrom's macroglobulinemia demonstrates the potent anti-tumor effect of second generation CD19 directed chimeric antigen receptor modified T cells in this disease
    Meeting Abstract

    Smith, E. L.; Palomba, M. L.; Park, J. H.; Brentjens, R. J.
    Blood (2014)

    Fulltext@MSK | Save
  • Efficacy and risk factors analysis of upfront autologous stem cell mobilization using plerixafor and granulocyte-colony stimulating factor (GCSF) in patients with multiple myeloma
    Meeting Abstract

    Ogunniyi, A.; Rodriguez, M.; Devlin, S. M.; Adel, N. G.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A. M.; Landgren, O.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • A phase Ib dose escalation trial of SAR650984 (anti-CD-38 mAb) in combination with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma
    Meeting Abstract

    Martin, T. G.; Baz, R.; Benson, D. M.; Lendvai, N.; Campana, F.; Charpentier, E.; Vij, R.
    Blood (2014)

    Fulltext@MSK | Save
  • Patterns of infectious morbidity in patients with Waldenstrom's macroglobulinaemia/lymphoplasmacytic lymphoma: A population-based study
    Meeting Abstract

    Lund, S. H.; Hultcrantz, M.; Goldin, L.; Landgren, O.; Bjorkholm, M.; Turesson, I.; Kristinsson, S. Y.
    Blood (2014)

    Fulltext@MSK | Save
  • Preliminary results of a phase I study of nivolumab (BMS-936558) in patients with relapsed or refractory lymphoid malignancies
    Meeting Abstract

    Lesokhin, A. M.; Ansell, S. M.; Armand, P.; Scott, E. C.; Halwani, A.; Gutierrez, M.; Millenson, M. M.; Cohen, A. D.; Schuster, S. J.; Lebovic, D.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Increased bone marrow plasma cells at diagnosis predicts overall mortality in AL amyloidosis patients undergoing risk-adapted stem cell transplant
    Meeting Abstract

    Landry, C. A.; Smith, M.; Chou, J. F.; Devlin, S. M.; Hassoun, H.; Bello, C.; Landgren, O.; Giralt, S.; Comenzo, R. L.; Landau, H.
    Blood (2014)

    Fulltext@MSK | Save
  • Carfilzomib, lenalidomide, and dexamethasone in high-risk smoldering multiple myeloma: Final results from the NCI phase 2 pilot study
    Meeting Abstract

    Landgren, O.; Roschewski, M.; Mailankody, S.; Kwok, M.; Manasanch, E. E.; Bhutani, M.; Tageja, N.; Kazandjian, D.; Zingone, A.; Costello, R.; more...
    Blood (2014)

    Fulltext@MSK | Save